Items where Author is "Kalantari, B."
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 2.
(2022) Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial. BMC Cancer. p. 10.
(2018) A Successful implementation of an idea to a nationally approved plan: Analyzing Iran's National Health Roadmap using the Kingdon model of policymaking. Med J Islam Repub Iran. p. 46. ISSN 1016-1430 (Print) 1016-1430 (Linking)